- ¥365bn
- ¥371bn
- ¥163bn
- 87
- 43
- 91
- 87
Annual cashflow statement for Organo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9,695 | 12,696 | 16,035 | 23,633 | 32,358 |
| Depreciation | |||||
| Non-Cash Items | 106 | -1,203 | 270 | 713 | -969 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -15,595 | -1,724 | -36,665 | -22,631 | -12,214 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4,582 | 11,101 | -18,536 | 3,725 | 21,100 |
| Capital Expenditures | -1,254 | -2,798 | -1,452 | -1,647 | -2,689 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -7 | 1,278 | 143 | 232 | 559 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,261 | -1,520 | -1,309 | -1,415 | -2,130 |
| Financing Cash Flow Items | -29 | -112 | -181 | -210 | -226 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4,927 | -2,586 | 14,706 | -641 | -20,821 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -968 | 7,393 | -4,639 | 2,084 | -891 |